Digital rendering of BeiGene's manufacturing site in Hopewell, NJ (Credit: BeiGene)
March 14, 2024 12:36 PM EDT
China
Manufacturing

BeiGene looks be­yond Chi­na as it se­cures new API source, nears open­ing of US site

Anna Brown

News Reporter

With many bio­phar­ma com­pa­nies au­dit­ing their man­u­fac­tur­ing sup­ply chains, BeiGene will soon ac­ti­vate a sec­ond API sup­pli­er out­side of Chi­na and will …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

Sarep­ta li­cens­es Ar­row­head­'s RNA-based rare dis­ease pipeline, promis­ing big biobucks

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

A service from the Financial Times